Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 01/21 03:21:45 pm
53.13 EUR   -1.06%
01/20PRESS RELEASE : Pfizer and BioNTech Publish -2-
DJ
01/20BAYER : Gets US FDA Approval For Vericiguat Drug
MT
01/20MERCK : Gets FDA Approval for Verquvo
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Hapag-Lloyd picks banks for planned IPO - sources

07/15/2015 | 09:57am EST
A Hapag-Lloyd container is loaded from a containership at the  terminal Altenwerder in the harbour in Hamburg.

FRANKFURT (Reuters) - German container shipping group Hapag-Lloyd [HPLG.UL] is speeding up preparations for an initial public offering (IPO) and has picked Deutsche Bank, Goldman Sachs and Berenberg to lead the transaction, two people familiar with the matter said.

A flotation of a minority stake could value the world's fourth-largest shipping group at more than 5 billion euros (3.5 billion pounds) and could take place as early as autumn, Dow Jones reported earlier on Wednesday.

Hapag Lloyd and the banks declined to comment.

When it announced its merger with the container shipping activities of Chilean rival Vapores (>> Compania Sud Americana de Vapores SA) last year, Hapag-Lloyd said it would seek to list on the stock exchange.

But CEO Rolf Habben Jansen said in May a flotation was more likely after 2015.

Europe's largest tourism group TUI (>> TUI AG), which holds 13.9 percent in Hapag, has stressed in the past that it wants to sell its stake in the event of an IPO as part of a strategy to focus solely on tourism activities.

The Vapores owner family holds 34 percent in the combined group, while the city of Hamburg holds 23.2 percent and entrepreneur Klaus-Michael Kuehne (>> Kuehne & Nagel International AG) holds 20.8 percent, with smaller stakes held by financial investors.

High stock market valuations have led several groups to speed up flotation plans.

In Germany, mortgage lender Pfandbriefbank [NUEG.UL], which is slated to have its debut on Thursday, opted for an early time slot.

Bayer's (>> Bayer AG) plastics maker Covestro, construction materials group Xella and packaging group Mauser [DUBAHI.UL] have also brought forward IPO plans.

Hapag-Lloyd swung to a first-quarter profit this year, thanks to the stronger U.S. dollar, lower fuel prices and the first effects of its merger.

Chief Executive Rolf Habben Jansen has previously said the company would like to get three or four good quarters under its belt before floating a minority stake.

(Reporting by Alexander Hübner and Arno Schuetze; additional reporting by Victoria Bryan; Editing by Georgina Prodhan)

By Arno Schuetze and Alexander Hübner


© Reuters 2015
Stocks mentioned in the article
ChangeLast1st jan.
BAYER AG -1.60% 52.84 Delayed Quote.11.51%
COMPAÑÍA SUD AMERICANA DE VAPORES S.A. 1.29% 32.89 End-of-day quote.14.72%
DEUTSCHE BANK AG -0.32% 9.16 Delayed Quote.2.68%
KUEHNE + NAGEL INTERNATIONAL AG 2.02% 207.5 Delayed Quote.1.29%
SEEK LIMITED 3.78% 28.82 End-of-day quote.1.02%
THE GOLDMAN SACHS GROUP, INC. -0.02% 290.331 Delayed Quote.11.56%
THE LEAD CO., INC. 0.85% 832 End-of-day quote.-0.95%
TUI AG 1.87% 4.788 Delayed Quote.-9.37%
All news about BAYER AG
01/20PRESS RELEASE : Pfizer and BioNTech Publish -2-
DJ
01/20BAYER : Gets US FDA Approval For Vericiguat Drug
MT
01/20MERCK : Gets FDA Approval for Verquvo
DJ
01/20BAYER : Gets FDA Approval for Heart-Failure Drug Vericiguat
DJ
01/20BAYER : U.S. FDA approves vericiguat for patients with symptomatic chronic heart..
PU
01/20BAYER AG : Credit Suisse sticks Neutral
MD
01/18GLOBAL MARKETS LIVE: Deliveroo, Zurich Insurance, Bayer…
01/18BAYER AG : JP Morgan sticks Neutral
MD
01/17Bayer aims to help CureVac with COVID-19 vaccine output, says CEO
RE
01/15Bans on GMO corn, glyphosate in Mexico would shrink food supplies, industry s..
RE
More news
Financials
Sales 2020 41 978 M 51 017 M 51 017 M
Net income 2020 -10 184 M -12 376 M -12 376 M
Net Debt 2020 33 823 M 41 105 M 41 105 M
P/E ratio 2020 -4,33x
Yield 2020 4,10%
Capitalization 51 911 M 63 045 M 63 088 M
EV / Sales 2020 2,04x
EV / Sales 2021 2,03x
Nbr of Employees 100 618
Free-Float 100,0%
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 61,87 €
Last Close Price 53,70 €
Spread / Highest target 58,3%
Spread / Average Target 15,2%
Spread / Lowest Target -14,3%
EPS Revisions
Managers and Directors
NameTitle
Werner Baumann Chairman-Management Board
Norbert Winkeljohann Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Bijoy Sagar Chief Information Technology Officer
Paul Achleitner Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG11.51%63 823
JOHNSON & JOHNSON3.18%427 472
ROCHE HOLDING AG3.56%308 129
NOVARTIS AG2.82%219 666
MERCK & CO., INC.0.81%208 627
PFIZER INC.-0.84%202 881